Patent · US Active

Anti-claudin antibodies and methods of use

US10053511B2 · kind B2 · utility

2Cited by
38References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2014
Grant dateAug 21, 2018
Priority date—
Expiry dateNov 5, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.